Cargando…
Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor Immunity
Treatment of cancer patients has been recently revolutionized by the application of various immunotherapeutics. However, the response rates are still limited ranging between approximately 20 and 40% suggesting that combinations of immunotherapy with conventional treatment, like chemotherapy, radiati...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538766/ https://www.ncbi.nlm.nih.gov/pubmed/31178856 http://dx.doi.org/10.3389/fimmu.2019.00999 |